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INFLUENCE OF FAMILY STRUCTURE ON EMERGENCY ROOM
UTILIZATION OF DIABETIC MOTHERS
Wingate L,Wang J, Hong SH, Ganguli A,White-Means S
University of Tennessee Health Science Center, Memphis,TN, USA
OBJECTIVE: This study is designed to determine if single dia-
betic mothers utilize emergency room services more frequently
when compared to coupled mothers. METHODS: Medical
Expenditure Panel Survey (MEPS) data from 2002–2005 were
used in this cross-sectional analysis. Mothers were included if
they had been told they had diabetes by a health care profes-
sional. Chi-square analysis was used to determine differences
between single and coupled mothers in regards to sociodemo-
graphic characteristics. Simple logistic regression was used to
determine if single diabetic mothers were more likely to visit the
emergency room than coupled mothers. Multivariate logistic
regression model was used to adjust for age, income, race, insur-
ance status, and education. The complex survey design of MEPS
including sampling strata, primary sampling units, and personal
weights were reﬂected in the analysis. An alpha level of 0.05 was
used to determine statistical signiﬁcance, and all analysis were
performed using SAS. RESULTS: Single diabetic mothers were
signiﬁcantly more likely to be black, and come from lower
income groups. Coupled diabetic mothers were signiﬁcantly
more likely to have a degree beyond high school, and to have
private insurance. Before adjustment for covariates , single dia-
betic mothers were 2.3 times as likely to use emergency room
than coupled mothers (p < 0.05). After adjustment for covari-
ates, single diabetic mothers were 1.9 times as likely to visit the
emergency room (95% conﬁdence interval: 1.15–3.14). CON-
CLUSION: Among diabetic mothers, being single is a signiﬁcant
risk factor in determining emergency room utilization. Further
research is needed to determine what factors place single diabetic
mothers at greater risk for emergency room use. Future interven-
tions designed to decrease emergency room use in diabetics may
be targeted to single mothers.
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INCREASED HOSPITALIZATIONS BY CHILDRENWITH
TYPE 2 DIABETES
Kim SH
Florida International University, Miami, FL, USA
OBJECTIVE: Type 2 diabetes has been reported with increasing
frequency among children aged 17 or younger (hereafter referred
to as “children”) in the United States (US). However, while it is
known that the prevalence of type 2 diabetes among children is
growing, there is little information about their hospital use. This
study is purposed to study the trend of hospitalizations with type
2 diabetes among children between the year 1997 and 2003 in
the US. METHODS: The study was based on the Kids Inpatient
Database (KID), a nationally representative probability sample
sponsored by the Agency of Health Research and Quality
(AHRQ). The KID, a database of hospital stays for children,
includes annually two million to three million pediatric inpatient
records selected from over 2500 to 3500 US community hospi-
tals. RESULTS: The numbers of hospitalization made by chil-
dren with type 2 diabetes were 2209, 4232, and 5840 in the year
1997, 2000, 2003, respectively. Adjusting for the growth of
population size, the rate of hospitalization with type 2 diabetes
was 2.5 times larger in 2003 compared to 1997. During the
same time period, the number of hospitalization made by
children with type 1 diabetes was 33,504, 35,541, and 36,439.
This growth of the hospitalization rate was the same as that of
the children population in US. Therefore, adjusting for the
population size, the rate of hospitalization with type 1 diabetes
remained the same. CONCLUSION: Given that the symptoms
of type 2 diabetes take a long time to develop, even small
numbers of hospitalizations are alarming. Furthermore, unlike
that of type 1 diabetes, the hospitalization with type 2 diabetes
was rapidly on the rise. With a continuous increase in obesity
among children, the burden of type 2 diabetes is a growing
public health concern.
DIABETES/ENDOCRINE DISORDERS—
Patient-Reported Outcomes
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A RESTROSPECTIVE ANALYSIS OF MEDICATIONS
ADHERENCE AND ASSOCIATED HEALTH CARE COST FOR
THE DIABETIC PATIENTS
Jing Y1, Sun SX2, Lee KY2,Ye X2, Huang Z2
1University of Cincinnati, Cincinnati, OH, USA, 2Walgreens Health
Services, Deerﬁeld, IL, USA
OBJECTIVE: Determine the adherence to diabetes medications
in the treatment of diabetic patients and associated health care
cost. METHODS: The study sample from a large PBM claims
database from January 1, 2005 through December 31, 2006.
Patients were included if they had diagnosis of diabetes, received
at least 1 diabetes medication and were continuously enrolled
during the study period. Medication adherence rates were
measured as percentage of days that the patient possessed any
available diabetic drug from July 1, 2005 to July 1, 2006. Each
study member was placed into 1 of 3 mutually exclusive adher-
ence category, deﬁned as 0 MPR < 0.5 (non-adherent group),
0.5 MPR < 0.8 (partially adherent group), 0.8 MPR  1
(adherent group). Descriptive analyses were conducted within
each category to assess the patient characteristics and health care
costs; Multivariate regression models were conducted to deter-
mine the impact of adherence on the health care costs controlling
for confounding factors. RESULTS: A total of 4262 patients
were included. Non-adherent, partially–adherent and adherent
patients accounts for 12.9%, 19.1% and 68.2% respectively. The
average diabetes-related medical care costs in the 18 months
post-index period decreased as the adherence level increased. The
average overall medical care costs in the 18 months post-index
period also decreased as the adherence level increased. The
average overall health care costs of partially adherent group and
adherent group are both lower than non-adherent group. After
controlling for patient characteristics, comorbidities, and health
care cost in the six months pre-index period the multivariate
regression showed low drug adherence level was signiﬁcant
predictors of both higher diabetes-related medical care costs
(p < 0.0001) and higher overall total medical care cost costs
(p < 0.001). CONCLUSION: Non-adherent diabetic patients
have higher diabetes-related and overall medical care cost
than partially adherent diabetic patients and adherent diabetic
patients. Investment in disease management programs to
promote adherence with medication regimen may needed for
these non-adherent diabetic patients.
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SYSTEMATIC REVIEW OF ADHERENCE, COMPLIANCE AND
QUALITY OF LIFE INTYPE 2 DIABETES PATIENTS
Kumar J1, Nair R2
1University of Toledo,Toledo, OH, USA, 2The University of Toledo,
Toledo, OH, USA
To evaluate the quality of life as an outcome of adherence and
compliance in type 2 diabetes and to predict the barriers and
strategies to improve adherence. Data were obtained by search-
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ing Pubmed between 2002 and 2007 for studies assessing quality
of life as an outcome due to adherence or compliance. Search
terms included were “Diabetes Mellitus Type 2, Compliance,
Medication Adherence” and various combinations of these
terms. There was no speciﬁc criterion to include or exclude
studies. All studies which ﬁt into the purpose for literature review
were analyzed. Patient education was found to be an intervention
that enhances the quality of life. Use of different drug and drug
delivery methods than conventional drugs were also found to
improve quality of life. Age, gender, and treatment problems
associated with insulin are risk factors for discontinuation and
non-adherence to medications. Older patients were found to be
adherent than younger patients. Forgetting to follow regimen,
disruption of routine and adverse effects were some barriers
reported in the literature. The main strategies for medication
adherence were found to be individualized daily routines,
reminder devices such as a day of the week, pillbox, and use of a
special place. There are not many studies done to date to evaluate
the quality of life as an outcome due to adherence and compli-
ance. Further research in this area will help better the under-
standing of relationship between quality of life as an outcome
due to adherence or compliance.
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DEVELOPMENT OF A CLASSIFICATION SYSTEM FOR
A DIABETES-SPECIFIC PREFERENCE-BASED
MEASURE OF HEALTH
Sundaram M, Smith MJ, Nath C
West Virginia University, Morgantown,WV, USA
OBJECTIVE: To develop a classiﬁcation system (CS) for a
diabetes-speciﬁc preference-based measure of health (PBMH).
METHODS: Plausible attributes for the PBMHwere identiﬁed by
Classical Test Theory, using Factor Analysis of responses
from Type 2 Diabetes patients (n = 385) to the 18-item Audit
of Diabetes-Dependent Quality of Life (ADDQoL). A seven-
member expert panel then provided qualitative input for content.
Three pilot rounds in outpatient and community settings pro-
duced data from people with Type 1 and Type 2 diabetes (n1 = 52,
n2 = 65, n3 = 111) that were analyzed usingModern Test Theory,
based onRaschAnalysis (RA), for 1) ﬁt of selected attributes to the
Rasch Model, and 2) scaling of severity levels for attributes.
RESULTS: Principal Axis Factoring with Promax rotation identi-
ﬁed two plausible attributes from six ADDQoL items. In a struc-
tured survey, experts rated the importance of all ADDQoL and
additionally important items, and suggested attributes that might
be described using sets of related items. A CS was developed
consisting of ﬁve independent attributes, with each question con-
taining a description based on the item content of the respective
attribute and four sentences describing severity levels. Maintain-
ing this format, the wording in the CS was further modiﬁed based
on additional input from experts andRA after each pilot. The ﬁnal
attributes were: Physical Ability & Energy, Relationships, Mood
& Feelings, Enjoyment of Diet, and Satisfaction with Manage-
ment of diabetes. Results of the third pilot indicated Inﬁt and
Outﬁt MNSQ for the ﬁve attributes ranging between 0.88 and
1.10. Person and Item reliabilities were 0.65 and 0.92, while the
respective separation ratios were 1.36 and 3.34. Severity levels
usedwere supported byRating Scale Diagnostics indicated byRA.
CONCLUSION: Results of the statistical analyses indicate that
the PBMH has desired psychometric properties. Research on the
estimation of a utility scoring algorithm and validation testing of
this PBMH is ongoing.
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PREFERENCES FOR ORAL ANTIDIABETIC AGENTS AMONG
PEOPLEWITHTYPE 2 DIABETES
Hauber AB1, Mohamed AF1, Johnson FR1, Falvey H2, Snyder E2
1RTI Health Solutions, Research Triangle Park, NC, USA,
2Novartis Pharma AG, Basel, Switzerland
OBJECTIVE: The objective of this study is to quantify the
strength of preferences and likely adherence to therapy of people
with type 2 diabetes mellitus (T2DM) for outcomes of oral
antidiabetic agents (OADs). METHODS: Currently many of the
available OADs for T2DM are associated with side effects such
as weight gain and nausea and vomiting. Understanding patient
preferences for medications with different attributes is important
for predicting likely adherence to OAD treatments with different
side-effects. We developed a web-based instrument to elicit treat-
ment preferences. Inclusion criteria were people 18 years of age
and older who were insulin-naïve and currently taking OADs to
treat T2DM. The instrument included ten stated-choice trade-off
tasks. Subjects chose between pairs of hypothetical medication
alternatives, each including change in HbA1c levels, number
of mild-to-moderate hypoglycemic events per month, water
retention, weight gain in the ﬁrst six months of treatment, mild
stomach upset, and risk of heart attack. Sample sizes were 200 in
the United States and 200 in the UK. RESULTS: The majority of
subjects were white, married, and female. Subjects were willing
to make tradeoffs between all medication attributes. On average,
subjects would accept signiﬁcant weight gain if the medication
yielded a reduction in HbA1c that resulted in optimal control
(6.5%). However, subjects’ stated adherence was signiﬁcantly
lower for treatments with weight gain, increased heart-attack
risk, or persistent nausea and vomiting. The UK sample was less
tolerant of hypoglycemic events. CONCLUSION: While people
with T2DM believe glucose control is important, medication
side-effects inﬂuence patients’ treatment choices. Efﬁcacy as
measured under controlled, clinical-trial conditions may over-
state actual treatment effectiveness as a result of patient concerns
over OAD side effects.
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CONTENT DEVELOPMENT FOR A NEW INSTRUMENTTO
ASSESS PATIENT AND PARENT PREFERENCE FOR GROWTH
HORMONE REPLACEMENTTHERAPY DELIVERY DEVICES
Stephens JM1, Carpiuc KT1, Gold KF2,Altman P3, Germak J3,
Joshi AV3
1Pharmerit North America LLC, Bethesda, MD, USA, 2Harvard
University, Cambridge, MA, USA, 3Novo Nordisk Inc, Princeton, NJ,
USA
OBJECTIVE: Few patient-reported outcome measures for
growth hormone (GH) replacement therapy have been formally
validated and none address preference for a particular delivery
method. Our objective was to formally develop a new instru-
ment to assess child and parent satisfaction with and preference
for GH therapy delivery devices. METHODS: An instrument
item pool was generated by combining the following four steps:
1) thorough literature review to identify relevant domains and
questions, 2) consultation with clinicians knowledgeable about
treatment of GH deﬁciency, 3) identiﬁcation of indicators spe-
ciﬁc to GH delivery devices, and 4) input from families with
children aged 10–16 years receiving GH therapy, including both
new (2 to 12 weeks) and established (12 weeks) users. Struc-
tured feedback forms were completed during cognitive inter-
views with focus groups on relevance of questions, missing
Abstracts A233
